top of page
Search

Preventing Blood Clots After Joint Replacement: Why Venous Thromboembolism Prophylaxis Matters

Writer: 骨科 郭峯志醫師
骨科 郭峯志醫師
4 hours ago
4 min read
Venous thromboembolism after joint replacement

After a knee or hip replacement, besides rehab and wound care, there is one risk that is “invisible but potentially fatal”: venous thromboembolism (VTE).

VTE includes deep vein thrombosis (DVT) and pulmonary embolism (PE). If a clot travels to the lungs, it can cause breathlessness and may even be life-threatening. That is why every patient having a joint replacement is advised to receive VTE prophylaxis (blood-clot prevention) unless there is a specific contraindication.

🩸 Why do blood clots form after joint replacement?

During surgery, blood flow in the legs temporarily slows. Together with reduced activity after surgery, tissue inflammation and activation of the clotting system, this makes clots more likely to form. Most clots start in the calf veins; if one breaks off, it can travel to the lungs and cause a pulmonary embolism, which is a medical emergency.

💊 Common prevention methods: medication plus mechanical protection

Based on the guidelines of the American College of Chest Physicians (ACCP) and the American Academy of Orthopaedic Surgeons (AAOS) [1][2][3][4][5], prevention after surgery falls into two main categories:

✅ 1. Pharmacological prophylaxis

The following types of medication can be used:

  • Low-molecular-weight heparin (LMWH): a traditional, reliable option

  • Direct oral anticoagulants (DOACs): such as rivaroxaban, apixaban and dabigatran

  • Fondaparinux or dose-adjusted warfarin

  • Aspirin: the first choice for low-risk patients, with growing evidence in recent years

👉 Low-risk patients (no history of clots, cancer or severe obesity): low-dose aspirin 81 mg twice daily can be used. Studies show it is effective and safe [6][7].

👉 High-risk patients (previous clots, cancer, severe obesity or an inherited clotting disorder): low-molecular-weight heparin or an oral anticoagulant (rivaroxaban or apixaban) is recommended [8][9][10]. These drugs are approved by the U.S. FDA for preventing blood clots after joint replacement [11].

✅ 2. Mechanical prophylaxis

If a patient temporarily cannot take anticoagulants (for example, because of a high bleeding risk), intermittent pneumatic compression devices or compression stockings can be used to help blood circulation.

⏱ How long should I take the medication?

According to research and guidelines [4][5][8][9]:

  • Generally for at least 10–14 days

  • After hip replacement, extended to 35 days

  • Combined throughout with getting out of bed early and appropriate rehab

🧍‍♀️ A real case

Mrs. Lin, 67, had a knee replacement.

She was recovering well but, worried about bleeding, wanted to stop the aspirin her doctor had prescribed. When her doctor learned this, he advised her not to, and explained the risk of blood clots and the safety of the dose. She followed the advice and completed the full 14 days.

She had no bleeding side effects and finished her rehab without problems. Had she stopped on her own, a blood clot could have become a ticking time bomb.

💬 Conclusion: preventing clots can save your life

Joint replacement can give you back your freedom of movement, but the small pill you take afterwards to prevent clots is often key to protecting your life.

Follow your doctor's instructions, don't stop the medication on your own, and combine it with early mobilisation and mechanical protection — this makes recovery after surgery safer and smoother.

Frequently Asked Questions

Q: Why do I need blood thinners after joint replacement?

A: Deep vein thrombosis can easily develop after surgery. If a clot travels to the lungs it causes a pulmonary embolism, which can be life-threatening. Unless there is a specific contraindication, blood-clot prevention is recommended for everyone.

Q: Is aspirin alone enough?

A: For low-risk patients, low-dose aspirin 81 mg twice daily is effective and safe. For high-risk patients — for example, those with previous clots, cancer or severe obesity — low-molecular-weight heparin or an oral anticoagulant is recommended.

Q: How long do I need to take the medication?

A: Generally for at least 10–14 days; after hip replacement, extended to 35 days.

Q: I'm worried about bleeding. Can I stop the medication myself?

A: Please don't stop on your own. If you have concerns, talk to your doctor first.

Q: What if I can't take blood thinners?

A: Intermittent pneumatic compression devices or compression stockings can be used to help blood circulation.

Q: Which symptoms mean I should seek medical help immediately?

A: Sudden swelling, pain or warmth in the calf, or sudden breathlessness, chest pain or coughing up blood — seek medical care right away.

📚 References

[1] Lieberman JR, Bell JA. Venous thromboembolic prophylaxis after total hip and knee arthroplasty. J Bone Joint Surg Am. 2021;103(16):1556–1564.

[2] Matharu GS, et al. Clinical effectiveness and safety of aspirin for venous thromboembolism prophylaxis after total hip and knee replacement. JAMA Intern Med. 2020;180(3):376–384.

[3] Karasavvidis T, et al. Prophylaxis for venous thromboembolic events in elective total hip and total knee arthroplasty. Curr Pharm Des. 2022;28(10):771–777.

[4] Lieberman JR, Pensak MJ. Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am. 2013;95(19):1801–1811.

[5] Deitelzweig SB, et al. Prevention of venous thromboembolism in the orthopedic surgery patient. Cleve Clin J Med. 2008;75(Suppl 3):S27–S36.

[6] Lavu MS, et al. Low-dose aspirin is the safest prophylaxis for prevention of venous thromboembolism after total knee arthroplasty across all patient risk profiles. J Bone Joint Surg Am. 2024;106(14):1256–1267.

[7] Mansour E, Ganz MP, Scuderi GR. Risk stratification for venous thromboembolism prophylaxis. Orthop Clin North Am. 2025;56(2):155–163.

[8] Khan F, et al. Venous thromboembolism. Lancet. 2021;398(10294):64–77.

[9] Anderson DR, et al. Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty. N Engl J Med. 2018;378(8):699–707.

[10] Yong BSJ, et al. Pharmacotherapy for venous thromboprophylaxis following total hip or knee arthroplasty: a systematic review and network meta-analysis. Semin Thromb Hemost. 2025;51(3):290–300.

[11] U.S. Food and Drug Administration. Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book).

 
 
 

Recent Posts

See All

Comments


bottom of page